| scholarly article | Q13442814 |
| P2093 | author name string | K Vinod Vijayan | |
| Miguel A Cruz | |||
| Qi Da | |||
| Juliana I Correa | |||
| Molly Behymer | |||
| P2860 | cites work | Mapping the glycoprotein Ib-binding site in the von willebrand factor A1 domain | Q22253890 |
| Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor | Q24317407 | ||
| Retracted: Vimentin Is a Novel Anti-Cancer Therapeutic Target; Insights from In Vitro and In Vivo Mice Xenograft Studies | Q28473693 | ||
| Platelet glycoprotein Ibalpha forms catch bonds with human WT vWF but not with type 2B von Willebrand disease vWF. | Q30483148 | ||
| Identification of cytokeratin 1 as a binding protein and presentation receptor for kininogens on endothelial cells | Q32081348 | ||
| In vivo relevance for platelet glycoprotein Ibalpha residue Tyr276 in thrombus formation. | Q33323650 | ||
| Evaluation of ADAMTS-13 activity in plasma using recombinant von Willebrand Factor A2 domain polypeptide as substrate | Q33357898 | ||
| Mapping the collagen-binding site in the I domain of the glycoprotein Ia/IIa (integrin alpha(2)beta(1)) | Q73413955 | ||
| von Willebrand factor without the A2 domain is resistant to proteolysis | Q73418285 | ||
| Vimentin exposed on activated platelets and platelet microparticles localizes vitronectin and plasminogen activator inhibitor complexes on their surface | Q77355818 | ||
| Variations among normal individuals in the cleavage of endothelial-derived ultra-large von Willebrand factor under flow | Q80435742 | ||
| Clinical and molecular predictors of thrombocytopenia and risk of bleeding in patients with von Willebrand disease type 2B: a cohort study of 67 patients | Q33381231 | ||
| The catalytic subunit of protein phosphatase 1 gamma regulates thrombin-induced murine platelet alpha(IIb)beta(3) function | Q33519081 | ||
| Vimentin and desmin possess GlcNAc-binding lectin-like properties on cell surfaces | Q33544952 | ||
| Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type IIA von Willebrand factor | Q33749366 | ||
| Destabilization of the A1 domain in von Willebrand factor dissociates the A1A2A3 tri-domain and provokes spontaneous binding to glycoprotein Ibalpha and platelet activation under shear stress | Q34003816 | ||
| Soluble CD44 interacts with intermediate filament protein vimentin on endothelial cell surface | Q34117459 | ||
| Vimentin is secreted by activated macrophages | Q34164992 | ||
| Selectin-like kinetics and biomechanics promote rapid platelet adhesion in flow: the GPIb(alpha)-vWF tether bond | Q34178256 | ||
| GPIbα-vWF rolling under shear stress shows differences between type 2B and 2M von Willebrand disease | Q34494411 | ||
| Platelets and cancer | Q34762260 | ||
| Vimentin in cancer and its potential as a molecular target for cancer therapy | Q35182104 | ||
| N-terminal flanking region of A1 domain in von Willebrand factor stabilizes structure of A1A2A3 complex and modulates platelet activation under shear stress. | Q35922561 | ||
| Novel functions of vimentin in cell adhesion, migration, and signaling | Q36826640 | ||
| Cell adhesion mechanisms in platelets | Q37049884 | ||
| Internalization of tissue factor by platelets. | Q37240164 | ||
| The endothelial cell-specific antibody PAL-E identifies a secreted form of vimentin in the blood vasculature | Q37527096 | ||
| Antithrombotic therapy for ischemic stroke: guidelines translated for the clinician | Q37686251 | ||
| von Willebrand factor: the old, the new and the unknown. | Q38047344 | ||
| Interaction of the von Willebrand factor (vWF) with collagen. Localization of the primary collagen-binding site by analysis of recombinant vWF a domain polypeptides | Q38295551 | ||
| Purified A2 domain of von Willebrand factor binds to the active conformation of von Willebrand factor and blocks the interaction with platelet glycoprotein Ibalpha | Q38303337 | ||
| Effect of deletion of the A1 domain of von Willebrand factor on its binding to heparin, collagen and platelets in the presence of ristocetin | Q38336125 | ||
| Regulation of cell adhesion to collagen via beta1 integrins is dependent on interactions of filamin A with vimentin and protein kinase C epsilon. | Q39737159 | ||
| Role of von Willebrand factor in tumor metastasis | Q40049065 | ||
| Von Willebrand's Disease and the Mechanisms of Platelet Function | Q40431932 | ||
| A di-acidic signal required for selective export from the endoplasmic reticulum | Q41098719 | ||
| Identification of amino acid residues essential for von Willebrand factor binding to platelet glycoprotein Ib. Charged-to-alanine scanning mutagenesis of the A1 domain of human von Willebrand factor | Q41336486 | ||
| Distinct structural attributes regulating von Willebrand factor A1 domain interaction with platelet glycoprotein Ibalpha under flow | Q41609653 | ||
| Modeling and functional analysis of the interaction between von Willebrand factor A1 domain and glycoprotein Ibalpha | Q41731691 | ||
| Electrostatic and hydrophobic interactions of the intermediate filament protein vimentin and its amino terminus with lipid bilayers | Q42212731 | ||
| Vimentin-mediated signalling is required for IbeA+ E. coli K1 invasion of human brain microvascular endothelial cells | Q43188647 | ||
| Aspects of hydrodynamic shear regulating shear-induced platelet activation and self-association of von Willebrand factor in suspension | Q44232585 | ||
| The platelet glycoprotein Ib-von Willebrand factor interaction activates the collagen receptor alpha2beta1 to bind collagen: activation-dependent conformational change of the alpha2-I domain | Q45129925 | ||
| Identification of a surface protein on human brain microvascular endothelial cells as vimentin interacting with Escherichia coli invasion protein IbeA. | Q45982337 | ||
| Cell surface expression of intermediate filament proteins vimentin and lamin B1 in human neutrophil spontaneous apoptosis | Q46859416 | ||
| Simultaneous exposure of sites in von Willebrand factor for glycoprotein Ib binding and ADAMTS13 cleavage: studies with ristocetin | Q47221868 | ||
| Inhibition of von Willebrand factor-GPIb/IX/V interactions as a strategy to prevent arterial thrombosis | Q47928285 | ||
| ADAMTS-13 activity in plasma is rapidly measured by a new ELISA method that uses recombinant VWF-A2 domain as substrate | Q47979889 | ||
| Structure of pre-pro-von Willebrand factor and its expression in heterologous cells | Q56459909 | ||
| Platelets Take Up the Monoclonal Antibody Bevacizumab | Q61971038 | ||
| Real-time analysis of shear-dependent thrombus formation and its blockade by inhibitors of von Willebrand factor binding to platelets | Q70585720 | ||
| A role for von Willebrand factor proline residues 702-704 in ristocetin-mediated binding to platelet glycoprotein Ib | Q70619343 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 17 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 7 | |
| P304 | page(s) | 2715-2721 | |
| P577 | publication date | 2014-03-18 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Platelet adhesion involves a novel interaction between vimentin and von Willebrand factor under high shear stress | |
| P478 | volume | 123 |
| Q30836660 | A recombinant fragment of von Willebrand factor reduces fibrin-rich microthrombi formation in mice with endotoxemia |
| Q91787897 | Ablation of miR-144 increases vimentin expression and atherosclerotic plaque formation |
| Q90026927 | Acquired Von Willebrand Syndrome (AVWS) in cardiovascular disease: a state of the art review for clinicians |
| Q35860907 | Cytokinetic Failure-induced Tetraploidy Develops into Aneuploidy, Triggering Skin Aging in Phosphovimentin-deficient Mice |
| Q57820726 | Extracellular Vimentin/VWF (von Willebrand Factor) Interaction Contributes to VWF String Formation and Stroke Pathology |
| Q36274849 | Free hemoglobin increases von Willebrand factor-mediated platelet adhesion in vitro: implications for circulatory devices |
| Q39367860 | Increased von Willebrand factor levels in patients with systemic lupus erythematosus reflect inflammation rather than increased propensity for platelet activation. |
| Q91660072 | Modulating the rate of fibrin formation and clot structure attenuates microvascular thrombosis in systemic inflammation |
| Q47655008 | Recombinant Human Vimentin Binds to P-Selectin and Blocks Neutrophil Capture and Rolling on Platelets and Endothelium |
| Q55153557 | The functions of the A1A2A3 domains in von Willebrand factor include multimerin 1 binding. |
| Q51825876 | The shear stess profile of the pivotal fenestrated endograft at the level of the renal branches: A computational study for complex aortic aneurysms. |
| Q58702541 | Vimentin Diversity in Health and Disease |
| Q102062021 | Vimentin's side gig: regulating cellular proteostasis in mammalian systems |
Search more.